An international research team led by the Medical University of Vienna has demonstrated for the first time that thyroid ...

Know someone who's been diagnosed with breast cancer? There's a good chance that person has received hormone therapy.

Two phase 3 trials suggest that the antibody drug conjugate led to significantly improved outcomes in both the neoadjuvant ...

An international research team led by the Medical University of Vienna has demonstrated for the first time that thyroid hormone plays a key role in the development and progression of prostate cancer.

Rates of an elusive type of breast cancer are rising in the US more than three times faster than those of all other breast ...

Verzenio plus endocrine therapy reduced death risk by 15.8% in high-risk early breast cancer patients compared to endocrine ...

This article was reviewed by Felix Gussone, MD. Low Testosterone and Joint Pain: What’s the Connection? Your knees, ankles, ...

Olema Pharmaceuticals faced a 30% stock drop after ESMO 2025 data on palazestrant, its lead breast cancer candidate. Click ...

Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early ...

The breast cancer pipeline presents significant opportunities with over 250 companies and 300+ drugs under development, including innovative approaches like PROTACs, ADCs, and CDK inhibitors. Focus ...

Recent studies reveal that triplet therapies significantly enhance progression-free survival in patients with ...